Neuro42 Company
Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
Total Funding:
7800000.0
Headquarters:
Oakland, California, United States
Funding Status:
Early Stage Venture
Last Funding Type:
Series A
Last Funding Date:
2021-07-27
Investors Number:
4.0
Founded Date:
2020-01-01
Industry:
Neurodegenerative disease diagnosis and treatment